Text Size

Educational Intervention Targeting Nurses Attitudes and Knowledge About Cancer-related Pain Management

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Blekinge Institute of Technology
ClinicalTrials.gov Identifier:
NCT01313234
First received: March 5, 2011
Last updated: January 5, 2013
Last verified: January 2013
History of Changes
  Purpose

The purpose of this study is to investigate whether an intervention consisting of the implementation of guidelines about daily systematic pain assessment following a theory based education, targeting cancer-related pain and pain treatment, lead to a significantly positive improvement in RNs knowledge of, and attitudes towards their pain management. Furthermore will the interventions targeting the RNs influence the admitted patient's perception of their cancer-related pain?


Condition Intervention
Neoplasms
 Behavioral: Education

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: A Theory Based Educational Intervention Targeting Nurses Attitudes and Knowledge Concerning Cancer-related Pain Management: A Study Protocol of a Quasi-experimental Study Design

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Blekinge Institute of Technology:

Primary Outcome Measures:
  • Change from baseline of the total score of Knowledge and Attitudes Survey Regarding Pain [ Time Frame: Measurement will occur at first session of the educational intervention and 2 and 6 weeks after ] [ Designated as safety issue: No ]
    Nurses attitude and knowledge as measured by a modified version of the instrument: Knowledge and Attitudes Survey Regarding Pain


Secondary Outcome Measures:
  • Change from Baseline - Brief Pain Inventory, Short Form (BPI-SF) [ Time Frame: Measurement will occur at admission of the patient and at discharge from the hospital. Estimated average time period from admission to discharge is 2 weeks ] [ Designated as safety issue: No ]
    BPI-SF is a pain-assessment instrument developed for cancer patient. The instrument consists of nine items, and a figure depicting a human body where the patient marks position and type of pain. BPI-SF includes items concerning the degree of pain right now, pain during the last day and pain on average as well as items concerning effect of pain treatment, walking ability, mood, work, relationships and if sleep are affected by pain.


Enrollment: 60
Study Start Date: April 2011
Study Completion Date: December 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Education
Educational theory based intervention and systematic daily pain assessment
 Behavioral: Education
Theory based education and systematic daily assessment
No Intervention: Control
Control group with care as usual

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cancer diagnosis
  • Aged 18 years and above
  • Cognitively intact and able to verbally communicate
  • At admission pain intensity >1 on Visual Analogue Scale (VAS)

Exclusion Criteria:

  • Trauma or planned and/or acute surgery.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01313234

Locations
Sweden
Blekinge Hospital
Karlskrona, Sweden, 37185
Sponsors and Collaborators
Blekinge Institute of Technology
  More Information

No publications provided by Blekinge Institute of Technology

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Blekinge Institute of Technology
ClinicalTrials.gov Identifier: NCT01313234     History of Changes
Other Study ID Numbers: BFR20100046019
Study First Received: March 5, 2011
Last Updated: January 5, 2013
Health Authority: Sweden: Institutional Review Board

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on June 17, 2013